Recent Press Releases

Cancer Genetics, Inc. Announces a Partnership with ICON to Offer Comprehensive Oncology Laboratory Testing & Solutions for the Global Biopharma Industry

RUTHERFORD, N.J. – Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"), an emerging leader in DNA-based diagnostics, announced today that it has entered into a...

APTUIT ANNOUNCES EXPANSION OF INTEGRATED CMC OFFERING (DRUG SUBSTANCE AND DRUG PRODUCT) TO PHASE 3 AND COMMERCIAL SCALE

Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license Greenwich, CT, - Aptuit LLC announced it has augmented...

Synexus Continues Expansion Across Eastern Europe with Three New Clinical Trial Centers

Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centres in Eastern Europe and a total network...

Frontage Laboratories Acquires BDM Consulting

EXTON, Pa.--Frontage Laboratories, a full-service contract research organization that helps clients reduce the time and cost of product development, has acquired BDM Consulting, of Summerset, N.J....

Catalent Biologics Adds New Technology Platform To Enable Antibody Combination Therapies

Somerset, N.J. – July 7, 2015 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...

Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest’s lead drug candidate SHACT

Recipharm Venture Fund AB has together with Östersjöstiftelsen and Praktikerinvest made a joint investment of SEK 28 million in Pharmanest AB. Recipharm's part of the investment is SEK...

PAREXEL Expands Model-Based Drug Development Offering

BOSTON, July 9, 2015 -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced expanded services and capabilities in model-based drug...

Charles River Laboratories to Acquire Celsis International Ltd.

– Enhances Charles River Endotoxin and Microbial Detection's Position as the Most Comprehensive Solution for Rapid Quality Control Testing – – Transaction Expected to be...

BioClinica Acquires MediciGroup

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that it has acquired a leading global patient recruitment and retention firm,...

Bracket Acquires Clintara In Move To Strengthen Rater Training, Quality Assurance, And Electronic Clinical Outcomes Assessment Capabilities

WAYNE, Pa. and BOSTON -- Bracket Global, LLC and Clintara are pleased to announce the two companies have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies...

Quintiles and Quest Diagnostics Launch Q² Solutions

RESEARCH TRIANGLE PARK, N.C. and MADISON, N.J. – July 2, 2015 – Quintiles and Quest Diagnostics today announced the launch of Q2 Solutions, their new combined clinical trials laboratory...

Akaal Pharma, Australia extends collaboration with GVK BIO for formulations development services to support Phase 2 Clinical studies for Topical Treatment of Psoriasis

Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical...

Society for Clinical Research Sites Welcomes Covance as its Newest Global Impact Partner

Ellicott City, M.D. – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a...

BioClinica Expands Operational Capabilities, Opens New European Offices

NEWTOWN, Pa. -- BioClinica®, Inc., the world's leading specialty clinical trial service provider, announced today the opening of new and expanded offices in London and Munich to better serve...

Ergomed Selected by Co-Development Partner Aeterna Zentaris to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen™ in AGHD

Guildford, UK – 25 June 2015: Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company, dedicated to the provision of specialised services to the pharmaceutical industry and...

Novasep invests €10M to reinforce its bioconjugation services

Expansion marks Novasep's readiness for full range Antibody Drug Conjugates CMO services Pompey, France, June 25, 2015 – Novasep, a leading supplier of services and technologies for the...

PRA CONTINUES THE TRANSFORMATION OF CLINICAL TRIALS WITH PREDICTIVV

PRA Health Sciences, a leading global contract research organization, today announced its new Predictivv™ platform, the beginning of an entirely new approach on the role technology will play in...

ICON Launches Firecrest Patient Portal to Enhance Education around Informed Consent

New Firecrest Patient Portal, part of ICONIK Informatics Hub, designed to enhance patient engagement and support patient recruitment and retention. DUBLIN--ICON plc, (NASDAQ: ICLR) a global provider...

Huntingdon Life Sciences and Harlan Laboratories to become Envigo

The combined company has been created through the integration of Huntingdon Life Sciences and Harlan Laboratories, and three subsidiaries: GFA, NDA Analytics and LSR associates. Huntingdon (UK)...

PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day

BOSTON -- In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has updated its forward-looking guidance for the fourth quarter of Fiscal Year...